Brenntag Specialties engages Esprit Care for its Southeast Asia nutraceutical market expansion
Brenntag Specialties Pharma marks a strategic milestone with its first collaboration with a contract manufacturer to enhance its nutraceutical value chain
Brenntag Specialties Pharma marks a strategic milestone with its first collaboration with a contract manufacturer to enhance its nutraceutical value chain
This product is indicated in coagulation disorders caused by vitamin K deficiency or interference with vitamin K activity.
Iskra has held leadership positions across Central & Eastern Europe, Eurasia, Middle East & Africa at AstraZeneca
The approved product has an estimated market size of US$ 106 million for the twelve months ending October 2024, according to IQVIA
Granules has undertaken a proactive, voluntary and comprehensive remediation plan to address the six form 483 observations raised by the USFDA
The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Xalatan
First GMP batch released at Lonza’s next-generation mammalian manufacturing facility in Portsmouth (US)
The collaboration offers opportunities for training, research fellowships, workshops and conferences at palliative care centers managed by Ajit Isaac Foundation
Subscribe To Our Newsletter & Stay Updated